Immunocore Holdings (IMCR) Long-Term Deferred Tax (2019 - 2025)

Immunocore Holdings has disclosed Long-Term Deferred Tax across 7 years of filings, most recently posting $14.3 million for Q3 2025.

• Long-Term Deferred Tax for Q3 2025 came in at $14.3 million, up 13.19% year-over-year; the trailing twelve-month figure through Sep 2025 was $14.3 million (up 13.19% YoY), and the FY2024 annual result was $14.8 million, up 34.79% from the prior year.
• Long-Term Deferred Tax came in at $14.3 million for Q3 2025 at Immunocore Holdings, up from $14.1 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $14.8 million in Q4 2024 to a low of $3.5 million in Q4 2021.
• The 5-year median for Long-Term Deferred Tax is $11.8 million (2023), against an average of $11.1 million.
• Across the five-year window, Long-Term Deferred Tax surged 120.64% in 2023 and rose 13.19% in 2025, its largest moves.
• Immunocore Holdings' Long-Term Deferred Tax stood at $3.5 million in 2021, then soared by 43.27% to $5.0 million in 2022, then soared by 120.64% to $11.0 million in 2023, then jumped by 34.79% to $14.8 million in 2024, then dropped by 3.09% to $14.3 million in 2025.
• The last three Long-Term Deferred Tax figures came in at $14.3 million (Q3 2025), $14.1 million (Q2 2025), and $14.4 million (Q1 2025), per Business Quant data.